Vaccines

132 articles
by Maddi Dellplain ... ...

Vaccines aren’t even the half of it

Family and emergency physician Erin Bearss led the vaccine rollout in six Toronto long-term care homes. We're profiling her as a Pillars of the Pandemic honouree.

by Max Binks-Collier

How good is natural immunity?

Is the immunity that comes from having caught COVID-19 as good as the immunity from vaccination? It may well be, at least for some – but there are caveats.

by Seema Marwaha

Do we need booster shots?

Healthy Debate Editor-in-Chief Seema Marwaha talks about how booster shots of the COVID-19 vaccines could help protect the immunocompromised – especially during the fourth wave – and, perhaps later on, the general public.

by Seema Marwaha

Weigh the risks and benefits of activities to keep your unvaccinated children safe

As the Delta variant pushes Canada into a fourth wave, Healthy Debate Editor-in-Chief Seema Marwaha discusses how to keep our children safe for the rest of the summer.

by Catharine Chambers

Five reasons why COVID-19 cases are increasing when vaccination rates are going up

Despite high vaccination coverage, COVID-19 cases are increasing in parts of Canada and experts are predicting a fourth wave this fall (or sooner). Here's why.

by Andrew Helmers

Vaccine passports: Moral baggage or all-inclusive destination?

When it comes to vaccine passports, perhaps the ends justify the means – they will increase vaccinations and benefit everyone. But perhaps we must also admit that they are, at best, only a small part of the solution to increasing vaccination.

by Seema Marwaha

Vaccine passports explained

A vaccine passport or identification system is a way to provide official proof of immunization when taking part in higher-risk activities. We break down what it looks like, who is doing it and what the ethical considerations might be.

by Catharine Chambers

Evaluating COVID vaccines: Clinical trials vs. observational studies

An epidemiologist breaks down the differences between short-term clinical trials and observational studies, and what each type of inquiry can tell us about how well vaccines work and how long they will last.

by Andria Bianchi

My vaccine status? It’s private

Asking people about their vaccination status may be well-intentioned, but it can violate their privacy and lead to negative consequences for them. It's time to reconsider asking about it during our regular public interactions.

by Paul Taylor

Patient Navigator: Do COVID vaccines work for people on immune-suppressing drugs?

People who take immune-suppressing drugs appear to be less protected by COVID vaccines than others – but ongoing research suggests there may be other ways for this group to stay safe.

by James Downar Maxwell Smith

Delaying second doses helped avert ICU catastrophe

It’s clear that when Ontario's ICUs were on the brink of being overwhelmed at the beginning of May, delaying second doses of the vaccines to have more people get one dose almost certainly helped avert catastrophe.

by Wendy Glauser

Speed and flexibility: Pop-up clinics highlight advantages of learning health systems

The COVID vaccine rollout is a litmus test for the learning health system. It requires speed, well-working collaborations with community members and the ability to adjust on the fly as supplies and eligibility requirements change.

by Miranda Caley

Vivid dreams and COVID arms: The weird vaccine ‘side effects’ you’re experiencing are likely harmless

Though COVID-19 vaccines are reported to have more intense side effects than a regular flu shot, this is merely a sign that your immune system is doing its job.

by Miranda Caley

When will your children be vaccinated? An update on COVID-19 vaccines for kids

Wondering when your kid will be able to get vaccinated? Miranda Caley provides an update on the studies that vaccine companies are conducting to test the safety and efficacy of vaccines for youth 18 and under.

by Multiple authors in collaboration

‘I got AstraZeneca for my first dose. Which should I get for my second?’ A COVID vaccination guide

If you had AstraZeneca for dose 1, you now have a choice. You can get AstraZeneca for dose 2 or you can get a dose of Moderna or Pfizer instead. We have some information you can use to weigh your options.

by Anne Borden King

‘This is the community in action’: Toronto’s Disability Vaccine Outreach Initiative

Disabled people are assisting their peers in gaining access to vaccines while also educating vaccine clinics about access needs. It's just one example of why involving communities in the rollout matters.

by Marisa Cicero Julie Maggi

We must limit barriers to vaccine access for children and youth

For Ontario to meet its goal of fully vaccinating children 12+ by the end of August, we must swiftly maximize access to clinics and minimize vaccine hesitancy.

by Sara Martel

Equal is not equitable: moral distress in health care

The inequity of Ontario's vaccine rollout is causing moral distress and burnout among health-care providers. How can we change the health-care system to make it more equitable and sustainable?

by Jillian Macklin

Making the most of the 15 minutes of post-jab waiting time

How can we make the most of the 15 minutes of medical observation that comes after getting vaccinated?

by Catharine Chambers

Why scary vaccine headlines are actually good news

We’ve all seen the headlines linking COVID-19 vaccines to rare blood clots. While this development may be worrisome, it is a reassuring sign that vaccine safety surveillance is doing its job.

3 of 7